P/E ratio for LeMaitre Vascular (LMAT)
P/E ratio as of April 2024 (TTM): 50.9
According to LeMaitre Vascular's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 50.9106. At the end of 2022 the company had a P/E ratio of 48.4.
P/E ratio history for LeMaitre Vascular from 2006 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 48.4 | 22.48% |
| 2021 | 39.6 | 2.54% |
| 2020 | 38.6 | -3.44% |
| 2019 | 39.9 | 99.38% |
| 2018 | 20.0 | -43.37% |
| 2017 | 35.4 | -20.42% |
| 2016 | 44.5 | 13.4% |
| 2015 | 39.2 | 17.87% |
| 2014 | 33.3 | -8.65% |
| 2013 | 36.4 | 7.83% |
| 2012 | 33.8 | -25.85% |
| 2011 | 45.5 | 162.33% |
| 2010 | 17.4 | -65.28% |
| 2009 | 50.0 | -576.19% |
| 2008 | -10.5 | -66.13% |
| 2007 | -31.0 | -32.83% |
| 2006 | -46.2 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Baxter BAX | 7.74 | -84.79% | 🇺🇸 USA |
 Boston Scientific BSX | 82.2 | 61.50% | 🇺🇸 USA |
 Edwards Lifesciences EW | 36.8 | -27.74% | 🇺🇸 USA |
 Teleflex TFX | 24.1 | -52.63% | 🇺🇸 USA |
 AngioDynamics ANGO | 38.3 | -24.87% | 🇺🇸 USA |
 Cardiovascular Systems CSII | -20.6 | -140.50% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.